Eventide Healthcare & Life Sciences A Profit Margin

Eventide Healthcare & Life Sciences A's profit margin stands at -136.13% as of May 2023. That compares with 989.03% in the prior-year period — down 113.8% year over year. That is below the sector sector average of 13.23%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Eventide Healthcare & Life Sciences A reported -136.13% in profit margin versus 989.03% a year earlier — a 113.8% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Eventide Healthcare & Life Sciences A sits lower the its sector benchmark (13.23%) with a profit margin of -136.13%. That is roughly 1129.3% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -136.13% for Eventide Healthcare & Life Sciences A means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Eventide Healthcare & Life Sciences A's profit margin evolved across reporting periods, while the comparison chart places ETAHX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.